Chen Qin-Yan, Harrison Tim J, Sabin Caroline A, Li Guo-Jian, Huang Gao-Ming, Yang Jin-Ye, Wang Xue-Yan, Li Hai, Liu Mo-Han, Fang Zhong-Liao
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Division of Medicine, Faculty of Medical Sciences, University College London, London, UK.
Hepat Mon. 2014 Feb 17;14(2):e16214. doi: 10.5812/hepatmon.16214. eCollection 2014 Feb.
Association of hepatitis B virus (HBV) genotype C with hepatocellular carcinoma (HCC) development remains controversial. HBV basal core promoter (BCP) double mutations (T(1762)A(1764)) are very strong confounding factors of genotypes B and C in HCC development.
To investigate the association of HBV genotype C with HCC development after controlling for BCP double mutations.
Four hundred and two serum samples from patients with HCC, liver cirrhosis (LC) and chronic hepatitis (CH) and also from asymptomatic HBsAg carriers were analyzed.
Genotypes B (31.1%), C (62.8%), and I (6.1%) were detected. With the severity of liver disease the prevalence of genotype B decreased, but genotype C increased. No trend was found for genotype I. The prevalence of BCP double mutations in genotypes C and I viruses was significantly higher than genotype B. BCP double mutations are risk factors for CH, LC and HCC. Genotype C was not identified as a particular risk factor for HCC prior to the stratification analysis but after that genotype C viruses with BCP double mutations were found to be a particular risk factor for HCC (P = 0.008, OR = 17.19 [95% CI: 2.10 - 140.41]), but those with the wild-type BCP were not. In the interaction analysis, genotype C and BCP double mutations were found to have a synergistic effect on HCC development (P < 0.0001, OR = 52.56 [95% CI: 11.49-240.52]).
The effect of HBV genotype C on the development of HCC differs between wild-type viruses and those with BCP double mutations, suggesting that not all individuals infected with genotype C HBV are at increased risk of HCC.
乙型肝炎病毒(HBV)C基因型与肝细胞癌(HCC)发生之间的关联仍存在争议。HBV基础核心启动子(BCP)双突变(T(1762)A(1764))是HCC发生过程中B和C基因型非常强的混杂因素。
在控制BCP双突变后,研究HBV C基因型与HCC发生之间的关联。
分析了来自HCC、肝硬化(LC)和慢性肝炎(CH)患者以及无症状HBsAg携带者的402份血清样本。
检测到B基因型(31.1%)、C基因型(62.8%)和I基因型(6.1%)。随着肝病严重程度的增加,B基因型的患病率下降,而C基因型的患病率上升。I基因型未发现趋势。C和I基因型病毒中BCP双突变的患病率显著高于B基因型。BCP双突变是CH、LC和HCC的危险因素。在分层分析之前,C基因型未被确定为HCC的特定危险因素,但在此之后,发现具有BCP双突变的C基因型病毒是HCC的特定危险因素(P = 0.008,OR = 17.19 [95% CI:2.10 - 140.41]),而具有野生型BCP的病毒则不是。在交互分析中,发现C基因型和BCP双突变对HCC发生有协同作用(P < 0.0001,OR = 52.56 [95% CI:11.49 - 240.52])。
HBV C基因型对HCC发生的影响在野生型病毒和具有BCP双突变的病毒之间有所不同,这表明并非所有感染C基因型HBV的个体患HCC的风险都会增加。